Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (3): 219-223    DOI: 10.19485/j.cnki.issn2096-5087.2024.03.009
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究
高菡璐1, 俞晓芳2, 吕乐彬3, 叶国良2, 樊金卿2
1.宁波大学附属第一医院防保科,浙江 宁波 315000;
2.宁波大学附属第一医院,浙江 宁波 315000;
3.宁波大学,浙江 宁波 315000
Interactions of multi-target stool DNA, intestinal flora, carcinoembryonic antigen and fruit intake on the risk of colorectal cancer
GAO Hanlu1, YU Xiaofang2, LÜ Lebin3, YE Guoliang2, FAN Jinqing2
1. Department of Preventive Care, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315000, China;
2. The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315000, China;
3. Ningbo University, Ningbo, Zhejiang 315000, China
全文: PDF(845 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨多靶点粪便DNA(MT-sDNA)、肠道菌群及饮食等环境因素之间的交互作用以及对结直肠癌的影响,为结直肠癌发病机制研究提供依据。方法 选择宁波大学附属第一医院结直肠癌病例54例纳入病例组,同期健康体检者51人纳入对照组,通过问卷调查收集人口学信息、饮食和结直肠癌家族史等资料;检测MT-sDNA、肠道菌群,以及癌抗原19-9、癌胚抗原(CEA)等肿瘤标志物;采用多因子降维法、叉生分析法和相加交互作用模型分析MT-sDNA、肠道菌群、环境因素的交互作用对结直肠癌患病的影响。结果 病例组年龄为(64.89±9.72)岁,男性20例,占37.04%,女性34例,占62.96%;对照组年龄为(53.94±10.33)岁,男性24人,占47.06%,女性27人,占52.94%。多因子降维法分析结果显示,同时有肠道菌群指数绝对值偏高和MT-sDNA阳性的人群患结直肠癌的风险较高(OR=3.782,95%CI:1.190~5.034)。叉生分析结果显示,MT-sDNA阳性与CEA>5 μg/L的人群患结直肠癌的风险较高(OR=2.121,95%CI:1.162~4.033)。相加模型分析结果显示,MT-sDNA与CEA存在正相加交互作用(SI=3.687,95%CI:1.229~7.238),MT-sDNA与吃水果存在负相加交互作用(SI=0.145,95%CI:0.020~0.753)。结论 MT-sDNA阳性可与肠道菌群指数偏高或CEA联合增加结直肠癌风险,吃水果可减少MT-sDNA阳性人群的结直肠癌风险。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
高菡璐
俞晓芳
吕乐彬
叶国良
樊金卿
关键词 结直肠癌多靶点粪便DNA肠道菌群肿瘤标志物交互作用    
AbstractObjective To explore the interaction of multi-target stool DNA (MT-sDNA), intestinal flora and environmental factors in the development of colorectal cancer, so as to provide insights into pathogenesis study of colorectal cancer. Methods A total of 54 cases of colorectal cancer from the First Affiliated Hospital of Ningbo University were included in the case group and 51 healthy subjects were included in the control group. Demographic information, diet and family history of colorectal cancer were collected by a questionnaire survey. MT-sDNA, intestinal flora, cancer antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA) and other tumor markers were detected. Interactions of MT-sDNA, intestinal flora and environmental factors with the development of colorectal cancer was analyzed by multifactor dimensionality reduction (MDR), crossover analysis and additive model. Results The case group included 20 males (37.04%) and 34 females (62.96%), and had a mean age of (64.89±9.72) years. The control group included 24 males (47.06%) and 27 females (52.94%), and had a mean age of (53.94±10.33) years. MDR analysis showed that subjects with both high absolute intestinal flora indexes and positive MT-sDNA had an increased risk of colorectal cancer (OR=3.782, 95%CI: 1.190-5.034). Crossover analysis showed that subjects with positive MT-sDNA and >5 μg/L of CEA had an increased risk of colorectal cancer (OR=2.121, 95%CI: 1.162-4.033). Additive model analysis showed that MT-sDNA had positive additive interaction with CEA (SI=3.687, 95%CI: 1.229-7.238), and MT-sDNA had negative additive interaction with fruit intake (SI=0.145, 95%CI: 0.020-0.753). Conclusion Positive MT-sDNA can synergistically increase the risk of colorectal cancer with high intestinal flora index and CEA, and fruit intake can reduce the risk of colorectal cancer in MT-sDNA-positive population.
Key wordscolorectal cancer    multi-target stool DNA    intestinal flora    tumor marker    interaction
收稿日期: 2023-05-24      修回日期: 2023-09-12      出版日期: 2024-03-10
中图分类号:  R735.3  
基金资助:浙江省卫生健康科技计划项目(2021KY1048,2022KY1142); 宁波市卫生健康青年技术骨干人才培养专项(2020SWSQNGG-02); 宁波市卫生高端团队重大攻坚项目(2023020612)
作者简介: 高菡璐,博士,副主任医师,主要从事慢性非传染性疾病流行病学、卫生经济学研究工作
通信作者: 樊金卿,E-mail:824803804@qq.com   
引用本文:   
高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
GAO Hanlu, YU Xiaofang, LÜ Lebin, YE Guoliang, FAN Jinqing. Interactions of multi-target stool DNA, intestinal flora, carcinoembryonic antigen and fruit intake on the risk of colorectal cancer. Preventive Medicine, 2024, 36(3): 219-223.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.03.009      或      https://www.zjyfyxzz.com/CN/Y2024/V36/I3/219
[1] 陈奇峰,陈康康,李金,等. 2011—2019年绍兴市结直肠癌发病趋势分析[J].预防医学,2021,33(11):1146-1148.
[2] CHEN H D,LI N,SHI J F,et al. Comparative evaluation of novel screening strategies for colorectal cancer screening in China(TARGET-C):a study protocol for a multicentre randomised controlled trial[J/OL]. BMJ Open,2019,9(4)[2023-09-12]. https://doi.org/10.1136/bmjopen-2018-025935.
[3] ANAND S,LIANG P S.A practical overview of the stool DNA test for colorectal cancer screening[J]. Clin Transl Gastroenterol,2022,13(4):1-4.
[4] 吕乐彬,樊金卿,赵王芳,等.肠镜检查人群多靶点粪便DNA检测意愿的影响因素分析[J].预防医学,2023,35(3):218-223.
[5] ZHAO L Y,ZHANG X,ZUO T,et al.The composition of colonic commensal bacteria according to anatomical localization in colorectal cancer[J]. Engineering,2017,10(3):90-97.
[6] TILG H,ADOLPH T E,GERNER R R,et al.The intestinal microbiota in colorectal cancer[J]. Cancer Cell,2018,33(6):954-964.
[7] GAO R Y,ZHU Y F,KONG C,et al.Alterations,interactions,and diagnostic potential of gut bacteria and viruses in colorectal cancer[J]. Front Cell Infect Microbiol,2021,11:1-13.
[8] SHEN W T,TANG D R,WAN P,et al.Identification of tissue-specific microbial profile of esophageal squamous cell carcinoma by full-length 16S rDNA sequencing[J]. Appl Microbiol Biotechnol,2022,106(8):3215-3129.
[9] JIN P,YOU P,FANG J Y,et al.Comparison of performance of two stool DNA tests and a fecal immunochemical test in detecting colorectal neoplasm:a multicenter diagnostic study[J]. Cancer Epidemiol Biomarkers Prev,2022,31:654-661.
[10] XU H L,CHEN H X,HU J J,et al.Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection[J]. BMC Gastroenterol,2022,22(1):1-8.
[11] DOUGLAS G M,MAFFEI V J,ZANEVELD J R,et al.PICRUSt2 for prediction of metagenome functions[J]. Nat Biotechnol,2020,38(6):685-688.
[12] GAO H L,LV L B,ZHAO W F,et al.Diagnostic accuracy of the multi-target stool DNA test in detecting colorectal cancer:a hospital-based study[J]. World J Gastrointest Oncol,2023,15(1):102-111.
[13] FAN J Q,ZHAO W F,LU Q W,et al.Fecal microbial biomarkers along with multi-target stool DNA improve the diagnostic accuracy in colorectal cancer[J]. World J Gastrointest Oncol,2023,15(8):1424-1435.
[14] SONG M,CHAN A T,SUN J.Influence of the gut microbiome,diet,and environment on risk of colorectal cancer[J]. Gastroenterology,2020,158(2):322-340.
[15] KENKHUIS M F,VAN DUIJNHOVEN F J B,VAN ROEKEL E H,et al. Longitudinal associations of fiber,vegetable,and fruit intake with quality of life and fatigue in colorectal cancer survivors up to 24 months posttreatment[J]. Am J Clin Nutr,2022,115(3):822-832.
[16] TAHA H M,SLADE A N,SCHWARTZ B,et al.A case-control study examining the association of fiber,fruit,and vegetable intake and the risk of colorectal cancer in a Palestinian population[J]. Int J Environ Res Public Health,2022,19(12):1-11.
[17] CAO X,YU G X,REN W,et al.DualWMDR:detecting epistatic interaction with dual screening and multifactor dimensionality reduction[J]. Hum Mutat,2020,41(3):719-734.
[1] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
[2] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[3] 查杰, 王达. 肠道菌群与非感染性胃肠炎的双向孟德尔随机化研究[J]. 预防医学, 2025, 37(8): 814-817.
[4] 何靖恺, 胡洁琼, 张加玏, 季蕴辛. 肠道菌群代谢产物与抑郁障碍研究进展[J]. 预防医学, 2025, 37(6): 583-587.
[5] 曾洁, 何娟, 许苑君, 王春. KCNQ1基因表达水平与痛风的关联研究[J]. 预防医学, 2025, 37(5): 481-485.
[6] 张莹, 陈伊绚, 高玥, 王晔, 李剑森, 韩毓桐, 魏文强, 廖羽. 2020年广东省肿瘤登记地区结直肠癌流行特征分析[J]. 预防医学, 2025, 37(10): 997-1001.
[7] 陈铭睿, 林玲, 楚楚, 黄捷, 韩亚蓉, 蔡波, 韩颖颖. 2013—2022年南通市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(10): 1039-1044.
[8] 陈颖, 刘可, 刘彬, 孙晓慧, 何志兴, 毛盈颖, 叶丁. 肠道菌群与多囊卵巢综合征的孟德尔随机化研究[J]. 预防医学, 2024, 36(9): 801-805.
[9] 胡珂杰, 熊加彬, 吴俊俊, 李珍, 朱伟琴, 李华铭. 五味苦参肠溶胶囊对溃疡性结肠炎大鼠肠道菌群的影响[J]. 预防医学, 2024, 36(8): 731-736.
[10] 蒋鸣孝, 李剑, 黄旭云. 上城区结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(6): 501-505.
[11] 和金金, 朱陈, 潘婷婷, 黄文雯, 蒋秉洁, 余炜燕, 王乐, 吴维妙, 杭栋, 杜灵彬. 定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J]. 预防医学, 2024, 36(4): 317-321.
[12] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[13] 沈方力, 茅俭英, 孟杨, 朱礼明, 柏红, 汤德珍, 刘世友. 宝山区居民结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(10): 869-872,877.
[14] 曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[15] 吕乐彬, 樊金卿, 赵王芳, 陆启文, 顾俊娣, 高菡璐. 肠镜检查人群多靶点粪便DNA检测意愿的影响因素分析[J]. 预防医学, 2023, 35(3): 218-223.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed